Yuanyuan Jin

Company: Bound Therapeutics

Job title: Co-founder & Chief Operating Officer

Seminars:

Targeted Extra-Hepatic Delivery of Custom Oligonucleotide-Peptide Conjugates for Enhanced Tumor Bioavailability, Efficacy, & Safety in a Breast Cancer Model 4:45 pm

How to design antisense oligonucleotide shortmers with custom RNA amidites for optimal efficacy and reduced off-target effects How to enhance tumor uptake and minimize liver accumulation of oligonucleotides via peptide ligand conjugation How to design tissue-specific peptide ligands for RNAi therapeutics using AI/ML-driven approach UNPUBLISHED DATARead more

day: Conference Day Two